From June 2015 is Henrik Rammer appointed as new chairman of the AddBIO board. Henrik has several years of experience in private equity and holding a position at Axcel during 2008-2013 and worked with Triton 2002-2007. Today Henrik is a private investor and board member in several Medtech companies beyond AddBIO, such as Chordate Medical, Sensa Bues, MYoroface, and the grocery store chain Paradiset. He holds a Bachelor of Science in economy from London School of Economics and Political Science from 1996.
Quote : “AddBIO’s combination technology is world unique yet still based on well-established components. I find it extremely satisfying to be a part of this product´s route to the market.”